Research progress of selenium combined with different drugs in the treatment of Hashimoto thyroiditis

doi:10.3877/cma.j.issn.2095-655X.2023.02.011

Abstract

Abstract:

Selenium is a trace mineral that is essential for maintaining human health. Selenium is present in the body as selenoproteins, which are involved in antioxidant, anti-inflammatory process, and the production of active thyroid hormone synthesis. The imbalance of oxidative stress and the downregulation of immune function that results from a lack of selenoproteins in the body may contribute to the occurrence and progression of Hashimoto thyroiditis (HT). Selenium supplementation may aid in the prevention and treatment of HT. The study of the relationship between selenium insufficiency and HT, as well as the prevention and treatment of selenium deficiency, has begun to attract domestic and international attention. This article discusses recent developments in selenium and its use in combination with other drugs for the prevention and treatment of HT.

Key words: Selenium, Hashimoto thyroiditis, Vitamin D, Thyroxine, Inositol

Zhengyu Wang, Lin Sun. Research progress of selenium combined with different drugs in the treatment of Hashimoto thyroiditis[J]. Chinese Journal of Diagnostics(Electronic Edition), 2023, 11(02): 125-127.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhzdxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-655X.2023.02.011

https://zhzdxdzzz.cma-cmc.com.cn/EN/Y2023/V11/I02/125

References 27

[1]	Ragusa F，Fallahi P，Elia G，et al.Hashimotos′ thyroiditis：epidemiology，pathogenesis，clinic and therapy[J].Best Pract Res Clin Endocrinol Metab，2019，33(6)：101367.DOI：10.1016/j.beem.2019.101367.
[2]	黄园园，刘亚楠，于世鹏. CD4⁺T淋巴细胞相关细胞因子与桥本氏甲状腺炎发病机制的研究进展[J/CD].中华诊断学电子杂志，2019，7(3)：214-216. DOI：10.3877/cma.j.issn.2095-655X.2019.03.016.
[3]	张国玉，万会娜，郭盼盼，等．桥本甲状腺炎发病因素及发病机制研究进展[J].新乡医学院学报，2020，37(10)：984-989，995.DOI：10.7683/xxyxyxb.2020.10.019.
[4]	Ralli M, Angeletti D, Fiore M, et al. Hashimoto′s thyroiditis：an update on pathogenicmechanisms，diagnostic protocols，therapeutic strategies，and potential malignant transformation[J].Autoimmun Rev，2020，19(10)：102649.DOI：10.1016/j.autrev.2020.102649.
[5]	Avery JC，Hoffmann PR.Selenium，selenoproteins，and immunity[J].Nutrients，2018，10(9)：1203.DOI：10.3390/nu10091203.
[6]	Weetman AP. An update on the pathogenesis of Hashimoto′s thyroiditis[J].J Endocrinol Invest，2021，44(5)：883-890.DOI：10.1007/s40618-020-01477-1.
[7]	Wu Q，Rayman MP，Lv H，et al.Low population selenium status is associated with increased prevalence of thyroid disease[J].J Clin Endocrinol Metab，2015，100(11)：4037-4047.DOI：10.1210/jc.2015-2222.
[8]	Hu S，Rayman MP.Multiple nutritional factors and the risk of Hashimoto's thyroiditis[J].Thyroid，2017，27(5)：597-610.DOI：10.1089/thy.2016.0635.
[9]	Rostami R，Nourooz-Zadeh S，Mohammadi A，et al.Serum selenium status and its interrelationship with serum biomarkers of thyroid function and antioxidant defense in Hashimoto's thyroiditis[J].Antioxidants (Basel)，2020，9(11)：1070.DOI：10.3390/antiox9111070.
[10]	Ventura M，Melo M，Carrilho F．Selenium and thyroid disease：from pathophysiology to treatment[J].Int J Endocrinol，2017(2017)：1297658.DOI：10.1155/2017/1297658.
[11]	Qian F，Misra S，Prabhu KS.Selenium and selenoproteins in prostanoid metabolism and immunity[J].Crit Rev Biochem Mol Biol，2019，54(6)：484-516.DOI：10.1080/10409238.2020.1717430.
[12]	Ghasemi F，Khoshmirsafa M，Safari E，et al.Vitamin E and selenium improve mesenchymal stem cell conditioned media immunomodulatory effects[J].Stem Cell Investig，2021(8)：9.DOI：10.21037/sci-2020-008.
[13]	Rayman MP. Selenium intake, status, and health: a complex relationship[J].Hormones (Athens)，2020，19(1)：9-14.DOI：10.1007/s42000-019-00125-5.
[14]	王宇璇，孟淑娟，王雅栋，等．人体内硒检测与富硒食品开发的研究进展[J].食品工业科技，2022，43(4)：428-437.DOI：10.13386/j.issn1002-0306.2021020057.
[15]	Ihnatowicz P，Drywien＇ M, Wtor P，et al.The importance of nutritional factors and dietary management of Hashimoto′s thyroiditis[J].Ann Agric Environ Med，2020，27(2)：184-193.DOI：10.26444/aaem/112331.
[16]	Charoenngam N，Holick MF.Immunologic effects of vitamin D on human health and disease[J].Nutrients，2020，12(7)：2097.DOI：10.3390/nu12072097.
[17]	卢婷.25羟基维生素D与桥本甲状腺炎的关系探讨[J].山西医药杂志，2022，51(2)：203-205.DOI：10.3969/j.issn.0253-9926.2022.02.023.
[18]	Krysiak R，Kowalcze K，Okopień B．Selenomethionine potentiates the impact of vitamin D on thyroid autoimmunity in euthyroid women with Hashimoto's thyroiditis and low vitamin D status[J].Pharmacol Rep，2019，71(2)：367-373.DOI：10.1016/j.pharep.2018.12.006.
[19]	侯丽萍，耿建林，谷巍，等．硒酵母联合维生素D对实验性自身免疫甲状腺炎大鼠甲状腺相关激素及抗体的影响[J].天津医药，2021，49(2)：136-141.DOI：10.11958/20201366.
[20]	Krysiak R，Okopien B．The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto′s thyroiditis[J].J Clin Endocrinol Metab，2011，96(7)：2206-2215.DOI：10.1210/jc.2010-2986.
[21]	Yu L, Zhou L, Xu E, et al. Levothyroxine monotherapy versus levothyroxine and selenium combination therapy in chronic lymphocytic thyroiditis[J].J Endocrinol Invest，2017，40(11)：1243-1250.DOI：10.1007/s40618-017-0693-z.
[22]	Wichman J，Winther KH，Bonnema SJ，et al.Selenium supplementation significantly reduces thyroid autoantibody levels in patients with chronic autoimmune thyroiditis：a systematic review and meta-analysis[J].Thyroid，2016，26(12)：1681-1692.DOI：10.1089/thy.2016.0256.
[23]	孙海君．硒酵母联合左旋甲状腺素片治疗桥本甲状腺炎的临床效果观察[J].中外女性健康研究，2020(9)：46-47.
[24]	任丽媛．硒酵母联合左旋甲状腺素治疗2型糖尿病伴桥本甲状腺炎的疗效、自身抗体水平及不良反应分析[J].当代医学，2020，26(26)：169-170.DOI：10.3969/j.issn.1009-4393.2020.26.074.
[25]	Krysiak R，Szkróbka W，Okopień B．The effect of hypolipidemic agents on thyroid autoimmunity in women with Hashimoto′s thyroiditis treated with levothyroxine and selenomethionine[J].Exp Clin Endocrinol Diabetes，2018，126(5)：321-326.DOI：10.1055/s-0043-120342.
[26]	Ferrari SM，Elia G，Ragusa F，et al.The protective effect of myo-inositol on human thyrocytes[J].Rev Endocr Metab Disord，2018，19(4)：355-362.DOI：10.1007/s11154-018-9476-x.
[27]	Nordio M，Basciani S．Myo-inositol plus selenium supplementation restores euthyroid state in Hashimoto′s patients with subclinical hypothyroidism[J].Eur Rev Med Pharmacol Sci，2017，21(2 Suppl)：51-59.

Please choose a citation manager

Content to export